The cannabidiol (CBD) products group noted that the “strong group sales momentum” had continued over the month with demand from both consumers and corporate clients.
Sativa said it is continuing to develop its core CBD offer, adding that the launch of its newly combined Goodbody website, goodbodystore.com, which features both the firm’s Wellness and Botanicals ranges, had proceeded “extremely well.
“This site provides the platform for product line expansion and focused efforts to drive sales growth”, the group said, adding that its new Goodbody Wellness line featuring CBD with vitamin D is being “received very well by both consumers and retailers”.
"We are delighted to see the continued sales momentum. We are working aggressively to build out both the platform online and expand the product range to anticipate and satisfy consumer demand”, Sativa chief executive Henry Lees-Buckley said in a statement.
“Our focus on regulatory compliance holds steadfast and we are actively engaged in the FSA Novel Foods accreditation process. Our combination with StillCanna Inc is on track and is expected close in early to mid-September. This creates a true ‘Seed to consumer CBD company’”, he added.
Shares in Sativa were trading at around 2.35p in late-morning on the Aquis Exchange on Tuesday.